img

Global Pharmacokinetics Testing Service Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pharmacokinetics Testing Service Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Pharmacokinetics Testing Service market is projected to reach US$ 535.5 million in 2029, increasing from US$ 327 million in 2022, with the CAGR of 7.5% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmacokinetics Testing Service market research.
The pharmacokinetics testing service market is expected to witness significant growth in the coming years. This can be attributed to the increasing demand for personalized medicine, rising prevalence of chronic diseases, and advancements in drug development and clinical trials.North America is expected to dominate the pharmacokinetics testing service market due to the presence of a well-established healthcare infrastructure, increasing R&D activities, and a large number of pharmaceutical companies in the region.Europe is also a significant market for pharmacokinetics testing services, driven by the presence of major pharmaceutical companies, increasing investments in drug development, and favorable government initiatives.The Asia Pacific region is expected to witness rapid growth in the pharmacokinetics testing service market due to the increasing outsourcing of drug development activities to countries like India and China, rising healthcare expenditure, and a large patient pool.The pharmacokinetics testing service market is highly fragmented, with the presence of numerous small and large players. However, a few major players dominate the market, accounting for a significant market share. These players have a strong presence in multiple regions and offer a wide range of pharmacokinetics testing services.The increasing focus on personalized medicine and targeted therapies presents significant opportunities for pharmacokinetics testing service providers. Personalized medicine requires precise pharmacokinetic data to determine the optimal drug dosage for individual patients.Technological advancements, such as the development of advanced analytical techniques and high-throughput screening methods, are expected to create new opportunities in the pharmacokinetics testing service market. These advancements enable faster and more accurate analysis of drug metabolism and pharmacokinetic parameters.The pharmacokinetics testing service market is subject to strict regulatory requirements, which can pose challenges for service providers. Compliance with regulatory guidelines and obtaining necessary approvals can be time-consuming and costly. Pharmacokinetics testing services can be expensive, especially for small and medium-sized pharmaceutical companies. The high cost of testing services can act as a barrier to market entry for some players and limit the adoption of these services.Overall, the pharmacokinetics testing service market is expected to grow significantly in the coming years, driven by factors such as the increasing demand for personalized medicine and advancements in drug development. However, challenges such as stringent regulatory requirements and high testing costs need to be addressed for the market to reach its full potential.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharmacokinetics Testing Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Proteomics International
Labcorp
Pharmaron
Svar
NorthEast BioLab
BioAgilytix
Washington Biotechnology, Inc.（WBI）
Eurofins BioPharma
Charles River
SCAS
Chimera
Phoenix WinNonlin
CD bioparticles
ACM Global Laboratories
WuXi AppTec
BioGenes
Pacific BioLabs
XenoTech
Medpace
SGS
CellCarta
Precision
Segment by Type
Microscale Thermophoresis
Mass Spectrometry

Segment by Application


Drug Development
Clinical Trials
Veterinary Medicine
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Pharmacokinetics Testing Service report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacokinetics Testing Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Microscale Thermophoresis
1.2.3 Mass Spectrometry
1.3 Market by Application
1.3.1 Global Pharmacokinetics Testing Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Drug Development
1.3.3 Clinical Trials
1.3.4 Veterinary Medicine
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacokinetics Testing Service Market Perspective (2018-2029)
2.2 Pharmacokinetics Testing Service Growth Trends by Region
2.2.1 Global Pharmacokinetics Testing Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pharmacokinetics Testing Service Historic Market Size by Region (2018-2024)
2.2.3 Pharmacokinetics Testing Service Forecasted Market Size by Region (2024-2029)
2.3 Pharmacokinetics Testing Service Market Dynamics
2.3.1 Pharmacokinetics Testing Service Industry Trends
2.3.2 Pharmacokinetics Testing Service Market Drivers
2.3.3 Pharmacokinetics Testing Service Market Challenges
2.3.4 Pharmacokinetics Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacokinetics Testing Service Players by Revenue
3.1.1 Global Top Pharmacokinetics Testing Service Players by Revenue (2018-2024)
3.1.2 Global Pharmacokinetics Testing Service Revenue Market Share by Players (2018-2024)
3.2 Global Pharmacokinetics Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacokinetics Testing Service Revenue
3.4 Global Pharmacokinetics Testing Service Market Concentration Ratio
3.4.1 Global Pharmacokinetics Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Testing Service Revenue in 2022
3.5 Pharmacokinetics Testing Service Key Players Head office and Area Served
3.6 Key Players Pharmacokinetics Testing Service Product Solution and Service
3.7 Date of Enter into Pharmacokinetics Testing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacokinetics Testing Service Breakdown Data by Type
4.1 Global Pharmacokinetics Testing Service Historic Market Size by Type (2018-2024)
4.2 Global Pharmacokinetics Testing Service Forecasted Market Size by Type (2024-2029)
5 Pharmacokinetics Testing Service Breakdown Data by Application
5.1 Global Pharmacokinetics Testing Service Historic Market Size by Application (2018-2024)
5.2 Global Pharmacokinetics Testing Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pharmacokinetics Testing Service Market Size (2018-2029)
6.2 North America Pharmacokinetics Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pharmacokinetics Testing Service Market Size by Country (2018-2024)
6.4 North America Pharmacokinetics Testing Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacokinetics Testing Service Market Size (2018-2029)
7.2 Europe Pharmacokinetics Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pharmacokinetics Testing Service Market Size by Country (2018-2024)
7.4 Europe Pharmacokinetics Testing Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacokinetics Testing Service Market Size (2018-2029)
8.2 Asia-Pacific Pharmacokinetics Testing Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pharmacokinetics Testing Service Market Size by Region (2018-2024)
8.4 Asia-Pacific Pharmacokinetics Testing Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacokinetics Testing Service Market Size (2018-2029)
9.2 Latin America Pharmacokinetics Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pharmacokinetics Testing Service Market Size by Country (2018-2024)
9.4 Latin America Pharmacokinetics Testing Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacokinetics Testing Service Market Size (2018-2029)
10.2 Middle East & Africa Pharmacokinetics Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pharmacokinetics Testing Service Market Size by Country (2018-2024)
10.4 Middle East & Africa Pharmacokinetics Testing Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Proteomics International
11.1.1 Proteomics International Company Detail
11.1.2 Proteomics International Business Overview
11.1.3 Proteomics International Pharmacokinetics Testing Service Introduction
11.1.4 Proteomics International Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.1.5 Proteomics International Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Detail
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Pharmacokinetics Testing Service Introduction
11.2.4 Labcorp Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.2.5 Labcorp Recent Development
11.3 Pharmaron
11.3.1 Pharmaron Company Detail
11.3.2 Pharmaron Business Overview
11.3.3 Pharmaron Pharmacokinetics Testing Service Introduction
11.3.4 Pharmaron Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.3.5 Pharmaron Recent Development
11.4 Svar
11.4.1 Svar Company Detail
11.4.2 Svar Business Overview
11.4.3 Svar Pharmacokinetics Testing Service Introduction
11.4.4 Svar Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.4.5 Svar Recent Development
11.5 NorthEast BioLab
11.5.1 NorthEast BioLab Company Detail
11.5.2 NorthEast BioLab Business Overview
11.5.3 NorthEast BioLab Pharmacokinetics Testing Service Introduction
11.5.4 NorthEast BioLab Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.5.5 NorthEast BioLab Recent Development
11.6 BioAgilytix
11.6.1 BioAgilytix Company Detail
11.6.2 BioAgilytix Business Overview
11.6.3 BioAgilytix Pharmacokinetics Testing Service Introduction
11.6.4 BioAgilytix Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.6.5 BioAgilytix Recent Development
11.7 Washington Biotechnology, Inc.（WBI）
11.7.1 Washington Biotechnology, Inc.（WBI） Company Detail
11.7.2 Washington Biotechnology, Inc.（WBI） Business Overview
11.7.3 Washington Biotechnology, Inc.（WBI） Pharmacokinetics Testing Service Introduction
11.7.4 Washington Biotechnology, Inc.（WBI） Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.7.5 Washington Biotechnology, Inc.（WBI） Recent Development
11.8 Eurofins BioPharma
11.8.1 Eurofins BioPharma Company Detail
11.8.2 Eurofins BioPharma Business Overview
11.8.3 Eurofins BioPharma Pharmacokinetics Testing Service Introduction
11.8.4 Eurofins BioPharma Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.8.5 Eurofins BioPharma Recent Development
11.9 Charles River
11.9.1 Charles River Company Detail
11.9.2 Charles River Business Overview
11.9.3 Charles River Pharmacokinetics Testing Service Introduction
11.9.4 Charles River Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.9.5 Charles River Recent Development
11.10 SCAS
11.10.1 SCAS Company Detail
11.10.2 SCAS Business Overview
11.10.3 SCAS Pharmacokinetics Testing Service Introduction
11.10.4 SCAS Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.10.5 SCAS Recent Development
11.11 Chimera
11.11.1 Chimera Company Detail
11.11.2 Chimera Business Overview
11.11.3 Chimera Pharmacokinetics Testing Service Introduction
11.11.4 Chimera Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.11.5 Chimera Recent Development
11.12 Phoenix WinNonlin
11.12.1 Phoenix WinNonlin Company Detail
11.12.2 Phoenix WinNonlin Business Overview
11.12.3 Phoenix WinNonlin Pharmacokinetics Testing Service Introduction
11.12.4 Phoenix WinNonlin Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.12.5 Phoenix WinNonlin Recent Development
11.13 CD bioparticles
11.13.1 CD bioparticles Company Detail
11.13.2 CD bioparticles Business Overview
11.13.3 CD bioparticles Pharmacokinetics Testing Service Introduction
11.13.4 CD bioparticles Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.13.5 CD bioparticles Recent Development
11.14 ACM Global Laboratories
11.14.1 ACM Global Laboratories Company Detail
11.14.2 ACM Global Laboratories Business Overview
11.14.3 ACM Global Laboratories Pharmacokinetics Testing Service Introduction
11.14.4 ACM Global Laboratories Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.14.5 ACM Global Laboratories Recent Development
11.15 WuXi AppTec
11.15.1 WuXi AppTec Company Detail
11.15.2 WuXi AppTec Business Overview
11.15.3 WuXi AppTec Pharmacokinetics Testing Service Introduction
11.15.4 WuXi AppTec Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.15.5 WuXi AppTec Recent Development
11.16 BioGenes
11.16.1 BioGenes Company Detail
11.16.2 BioGenes Business Overview
11.16.3 BioGenes Pharmacokinetics Testing Service Introduction
11.16.4 BioGenes Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.16.5 BioGenes Recent Development
11.17 Pacific BioLabs
11.17.1 Pacific BioLabs Company Detail
11.17.2 Pacific BioLabs Business Overview
11.17.3 Pacific BioLabs Pharmacokinetics Testing Service Introduction
11.17.4 Pacific BioLabs Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.17.5 Pacific BioLabs Recent Development
11.18 XenoTech
11.18.1 XenoTech Company Detail
11.18.2 XenoTech Business Overview
11.18.3 XenoTech Pharmacokinetics Testing Service Introduction
11.18.4 XenoTech Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.18.5 XenoTech Recent Development
11.19 Medpace
11.19.1 Medpace Company Detail
11.19.2 Medpace Business Overview
11.19.3 Medpace Pharmacokinetics Testing Service Introduction
11.19.4 Medpace Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.19.5 Medpace Recent Development
11.20 SGS
11.20.1 SGS Company Detail
11.20.2 SGS Business Overview
11.20.3 SGS Pharmacokinetics Testing Service Introduction
11.20.4 SGS Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.20.5 SGS Recent Development
11.21 CellCarta
11.21.1 CellCarta Company Detail
11.21.2 CellCarta Business Overview
11.21.3 CellCarta Pharmacokinetics Testing Service Introduction
11.21.4 CellCarta Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.21.5 CellCarta Recent Development
11.22 Precision
11.22.1 Precision Company Detail
11.22.2 Precision Business Overview
11.22.3 Precision Pharmacokinetics Testing Service Introduction
11.22.4 Precision Revenue in Pharmacokinetics Testing Service Business (2018-2024)
11.22.5 Precision Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pharmacokinetics Testing Service Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Microscale Thermophoresis
Table 3. Key Players of Mass Spectrometry
Table 4. Global Pharmacokinetics Testing Service Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Pharmacokinetics Testing Service Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Pharmacokinetics Testing Service Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Pharmacokinetics Testing Service Market Share by Region (2018-2024)
Table 8. Global Pharmacokinetics Testing Service Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Pharmacokinetics Testing Service Market Share by Region (2024-2029)
Table 10. Pharmacokinetics Testing Service Market Trends
Table 11. Pharmacokinetics Testing Service Market Drivers
Table 12. Pharmacokinetics Testing Service Market Challenges
Table 13. Pharmacokinetics Testing Service Market Restraints
Table 14. Global Pharmacokinetics Testing Service Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Pharmacokinetics Testing Service Market Share by Players (2018-2024)
Table 16. Global Top Pharmacokinetics Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetics Testing Service as of 2022)
Table 17. Ranking of Global Top Pharmacokinetics Testing Service Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Pharmacokinetics Testing Service Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pharmacokinetics Testing Service Product Solution and Service
Table 21. Date of Enter into Pharmacokinetics Testing Service Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharmacokinetics Testing Service Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Pharmacokinetics Testing Service Revenue Market Share by Type (2018-2024)
Table 25. Global Pharmacokinetics Testing Service Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Pharmacokinetics Testing Service Revenue Market Share by Type (2024-2029)
Table 27. Global Pharmacokinetics Testing Service Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Pharmacokinetics Testing Service Revenue Market Share by Application (2018-2024)
Table 29. Global Pharmacokinetics Testing Service Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Pharmacokinetics Testing Service Revenue Market Share by Application (2024-2029)
Table 31. North America Pharmacokinetics Testing Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Pharmacokinetics Testing Service Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Pharmacokinetics Testing Service Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Pharmacokinetics Testing Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Pharmacokinetics Testing Service Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Pharmacokinetics Testing Service Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Pharmacokinetics Testing Service Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Pharmacokinetics Testing Service Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Pharmacokinetics Testing Service Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Pharmacokinetics Testing Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Pharmacokinetics Testing Service Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Pharmacokinetics Testing Service Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Pharmacokinetics Testing Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Pharmacokinetics Testing Service Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Pharmacokinetics Testing Service Market Size by Country (2024-2029) & (US$ Million)
Table 46. Proteomics International Company Detail
Table 47. Proteomics International Business Overview
Table 48. Proteomics International Pharmacokinetics Testing Service Product
Table 49. Proteomics International Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 50. Proteomics International Recent Development
Table 51. Labcorp Company Detail
Table 52. Labcorp Business Overview
Table 53. Labcorp Pharmacokinetics Testing Service Product
Table 54. Labcorp Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 55. Labcorp Recent Development
Table 56. Pharmaron Company Detail
Table 57. Pharmaron Business Overview
Table 58. Pharmaron Pharmacokinetics Testing Service Product
Table 59. Pharmaron Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 60. Pharmaron Recent Development
Table 61. Svar Company Detail
Table 62. Svar Business Overview
Table 63. Svar Pharmacokinetics Testing Service Product
Table 64. Svar Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 65. Svar Recent Development
Table 66. NorthEast BioLab Company Detail
Table 67. NorthEast BioLab Business Overview
Table 68. NorthEast BioLab Pharmacokinetics Testing Service Product
Table 69. NorthEast BioLab Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 70. NorthEast BioLab Recent Development
Table 71. BioAgilytix Company Detail
Table 72. BioAgilytix Business Overview
Table 73. BioAgilytix Pharmacokinetics Testing Service Product
Table 74. BioAgilytix Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 75. BioAgilytix Recent Development
Table 76. Washington Biotechnology, Inc.（WBI） Company Detail
Table 77. Washington Biotechnology, Inc.（WBI） Business Overview
Table 78. Washington Biotechnology, Inc.（WBI） Pharmacokinetics Testing Service Product
Table 79. Washington Biotechnology, Inc.（WBI） Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 80. Washington Biotechnology, Inc.（WBI） Recent Development
Table 81. Eurofins BioPharma Company Detail
Table 82. Eurofins BioPharma Business Overview
Table 83. Eurofins BioPharma Pharmacokinetics Testing Service Product
Table 84. Eurofins BioPharma Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 85. Eurofins BioPharma Recent Development
Table 86. Charles River Company Detail
Table 87. Charles River Business Overview
Table 88. Charles River Pharmacokinetics Testing Service Product
Table 89. Charles River Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 90. Charles River Recent Development
Table 91. SCAS Company Detail
Table 92. SCAS Business Overview
Table 93. SCAS Pharmacokinetics Testing Service Product
Table 94. SCAS Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 95. SCAS Recent Development
Table 96. Chimera Company Detail
Table 97. Chimera Business Overview
Table 98. Chimera Pharmacokinetics Testing Service Product
Table 99. Chimera Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 100. Chimera Recent Development
Table 101. Phoenix WinNonlin Company Detail
Table 102. Phoenix WinNonlin Business Overview
Table 103. Phoenix WinNonlin Pharmacokinetics Testing Service Product
Table 104. Phoenix WinNonlin Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 105. Phoenix WinNonlin Recent Development
Table 106. CD bioparticles Company Detail
Table 107. CD bioparticles Business Overview
Table 108. CD bioparticles Pharmacokinetics Testing Service Product
Table 109. CD bioparticles Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 110. CD bioparticles Recent Development
Table 111. ACM Global Laboratories Company Detail
Table 112. ACM Global Laboratories Business Overview
Table 113. ACM Global Laboratories Pharmacokinetics Testing Service Product
Table 114. ACM Global Laboratories Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 115. ACM Global Laboratories Recent Development
Table 116. WuXi AppTec Company Detail
Table 117. WuXi AppTec Business Overview
Table 118. WuXi AppTec Pharmacokinetics Testing Service Product
Table 119. WuXi AppTec Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 120. WuXi AppTec Recent Development
Table 121. BioGenes Company Detail
Table 122. BioGenes Business Overview
Table 123. BioGenes Pharmacokinetics Testing Service Product
Table 124. BioGenes Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 125. BioGenes Recent Development
Table 126. Pacific BioLabs Company Detail
Table 127. Pacific BioLabs Business Overview
Table 128. Pacific BioLabs Pharmacokinetics Testing Service Product
Table 129. Pacific BioLabs Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 130. Pacific BioLabs Recent Development
Table 131. XenoTech Company Detail
Table 132. XenoTech Business Overview
Table 133. XenoTech Pharmacokinetics Testing Service Product
Table 134. XenoTech Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 135. XenoTech Recent Development
Table 136. Medpace Company Detail
Table 137. Medpace Business Overview
Table 138. Medpace Pharmacokinetics Testing Service Product
Table 139. Medpace Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 140. Medpace Recent Development
Table 141. SGS Company Detail
Table 142. SGS Business Overview
Table 143. SGS Pharmacokinetics Testing Service Product
Table 144. SGS Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 145. SGS Recent Development
Table 146. CellCarta Company Detail
Table 147. CellCarta Business Overview
Table 148. CellCarta Pharmacokinetics Testing Service Product
Table 149. CellCarta Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 150. CellCarta Recent Development
Table 151. Precision Company Detail
Table 152. Precision Business Overview
Table 153. Precision Pharmacokinetics Testing Service Product
Table 154. Precision Revenue in Pharmacokinetics Testing Service Business (2018-2024) & (US$ Million)
Table 155. Precision Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacokinetics Testing Service Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Pharmacokinetics Testing Service Market Share by Type: 2022 VS 2029
Figure 3. Microscale Thermophoresis Features
Figure 4. Mass Spectrometry Features
Figure 5. Global Pharmacokinetics Testing Service Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Pharmacokinetics Testing Service Market Share by Application: 2022 VS 2029
Figure 7. Drug Development Case Studies
Figure 8. Clinical Trials Case Studies
Figure 9. Veterinary Medicine Case Studies
Figure 10. Other Case Studies
Figure 11. Pharmacokinetics Testing Service Report Years Considered
Figure 12. Global Pharmacokinetics Testing Service Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Pharmacokinetics Testing Service Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Pharmacokinetics Testing Service Market Share by Region: 2022 VS 2029
Figure 15. Global Pharmacokinetics Testing Service Market Share by Players in 2022
Figure 16. Global Top Pharmacokinetics Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetics Testing Service as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Pharmacokinetics Testing Service Revenue in 2022
Figure 18. North America Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Pharmacokinetics Testing Service Market Share by Country (2018-2029)
Figure 20. United States Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Pharmacokinetics Testing Service Market Share by Country (2018-2029)
Figure 24. Germany Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Pharmacokinetics Testing Service Market Share by Region (2018-2029)
Figure 32. China Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Pharmacokinetics Testing Service Market Share by Country (2018-2029)
Figure 40. Mexico Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Pharmacokinetics Testing Service Market Share by Country (2018-2029)
Figure 44. Turkey Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Pharmacokinetics Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Proteomics International Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 47. Labcorp Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 48. Pharmaron Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 49. Svar Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 50. NorthEast BioLab Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 51. BioAgilytix Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 52. Washington Biotechnology, Inc.（WBI） Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 53. Eurofins BioPharma Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 54. Charles River Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 55. SCAS Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 56. Chimera Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 57. Phoenix WinNonlin Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 58. CD bioparticles Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 59. ACM Global Laboratories Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 60. WuXi AppTec Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 61. BioGenes Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 62. Pacific BioLabs Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 63. XenoTech Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 64. Medpace Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 65. SGS Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 66. CellCarta Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 67. Precision Revenue Growth Rate in Pharmacokinetics Testing Service Business (2018-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries